SEC 13F Intelligence

Ghost Tree Capital, LLC / ALDX

Ghost Tree Capital, LLC’s Aldeyra Therapeutics Inc Position

Does Ghost Tree Capital, LLC own Aldeyra Therapeutics Inc (ALDX)? Not currently — the last reported position was 700.0K shares worth $6M in Q3 2021; the fund’s latest 13F (Q3 2024) no longer reports it.

Position Value
$6M
Q3 2021
Shares
700.0K
% of Portfolio
+1.80%
Quarters Held
6
position exited

Position History ALDX

Reported value by quarter
Q2 ’20: $4MQ2 ’20Q3 ’20: $9MQ3 ’20Q4 ’20: $4MQ4 ’20Q1 ’21: $8MQ1 ’21Q2 ’21: $7MQ2 ’21Q3 ’21: $6MQ3 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2021700.0K$6M+1.80%
Q2 2021600.0K$7M+1.87%
Q1 2021650.0K$8M+1.81%
Q4 2020650.0K$4M+0.99%
Q3 20201.25M$9M+2.68%
Q2 20201.00M$4M+1.10%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Ghost Tree Capital, LLC’s full portfolio or all institutional holders of ALDX.